DigestRedComo funciona
Red
/
Empresas
Al
No verificado

Alamar Biosciences, Inc.

Sobre qué escribimos

BiologíaBiotecnologíaEconomíaFarmacéuticaSanidad

17 Comunicados de prensa

Ver todos los comunicados de prensa
28/07/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
12/07/2026
Biotecnología
Medicina Salud Bienestar
Gestión empresarial/Administración de Empresas
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
10/07/2026
Biotecnología
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
07/07/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
02/06/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
17/03/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
Fuente
Alamar Biosciences, Inc.
Editor
GLOBENEWSWIRE
1.00
0
Press Release cover image
29/07/2025
Salud
Fitness
Sociedad/Prensa del corazón
Crónica de sociedad
Empresas
Industria
Medicina - Varios
Medio Ambiente/Ecología
Agricultura
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
Fuente
Alamar Biosciences, Inc.
Editor
PR News Wire
1.00
0
Press Release cover image
28/07/2025
Salud
Fitness
Ferias y Congresos
Eventos
Medicina - Varios
Medio Ambiente/Ecología
Agricultura
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)
Fuente
Alamar Biosciences, Inc.
Editor
PR News Wire
1.00
0
28/05/2025
Farmacéutica
Sanidad
Economía
Patentes, marcas y derechos de autor
Biología
Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease
Fuente
Alamar Biosciences, Inc.
Editor
PR News Wire
1.00
0
15/05/2025
Farmacéutica
Tecnología de la información
Telecomunicaciones
Sanidad
Biología
Alamar Biosciences Expands NULISAseq(TM) CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays
Fuente
Alamar Biosciences, Inc.
Editor
PR News Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0